Can shingles present bilaterally on the flanks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Shingles Presentation on Bilateral Flanks

Shingles (herpes zoster) typically presents as a unilateral vesicular eruption in a dermatomal distribution and bilateral presentation on the flanks is atypical but can occur in immunocompromised patients or in cases of disseminated zoster infection 1.

Typical Presentation of Shingles

  • Herpes zoster classically presents with a unilateral vesicular eruption following a dermatomal distribution 1
  • The rash is usually preceded by prodromal pain that occurs 24-72 hours before skin findings appear 1
  • Lesions progress from erythematous macules to papules and then to vesicles, continuing to erupt for 4-6 days in immunocompetent hosts 1
  • The total disease duration is approximately 2 weeks in otherwise healthy individuals 1
  • The distinctive sign is a vesicular dermatomal rash or ulceration, typically affecting one side of the body 2

Atypical Presentations

  • While herpes zoster is typically unilateral, it can present bilaterally in certain circumstances 2
  • Immunocompromised patients may develop more extensive disease with atypical presentations, including bilateral involvement 3, 1
  • Recipients of blood, bone marrow, or solid organ transplants are at higher risk for developing atypical herpes zoster presentations 1
  • In immunocompromised hosts, skin lesions may continue to develop over a longer period and generally heal more slowly 4
  • Disseminated zoster (defined as >20 lesions outside the primary and adjacent dermatomes) can present with bilateral involvement 3

Diagnostic Considerations

  • Clinical diagnosis of bilateral shingles should prompt consideration of immune status evaluation 1
  • Laboratory confirmation is essential for atypical presentations, with viral culture, PCR, or antigen detection being available methods 4
  • Consider alternative diagnoses that may mimic herpes zoster, especially when the presentation is bilateral 1
  • Tzanck smear showing giant cells can be diagnostic for herpesvirus infection 1
  • Vesicle fluid specimens can be obtained for immunofluorescence antigen testing, culture, or PCR to confirm diagnosis 1

Management Implications

  • For uncomplicated herpes zoster, oral acyclovir or valacyclovir are the recommended first-line treatments 3
  • For disseminated or invasive herpes zoster (which may present bilaterally), intravenous acyclovir is recommended 3
  • In immunocompromised patients with disseminated disease, temporary reduction in immunosuppressive medication should be considered alongside antiviral therapy 3
  • High-dose IV acyclovir remains the treatment of choice for VZV infections in severely compromised hosts 3
  • Treatment should be continued until all lesions have scabbed 3

Clinical Pitfalls and Caveats

  • Bilateral presentation should raise suspicion for an immunocompromised state or disseminated disease 1
  • Lack of typical dermatomal distribution may lead to delayed diagnosis and treatment 5
  • Secondary bacterial and fungal superinfections can occur, particularly in immunocompromised hosts with atypical presentations 1
  • Topical antiviral therapy is substantially less effective than systemic therapy and is not recommended 3
  • Bilateral presentation may be confused with other vesicular eruptions, emphasizing the importance of laboratory confirmation in atypical cases 4

References

Guideline

Herpes Zoster Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Herpes Simplex Virus Lesion Presentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.